SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 3 TO
SCHEDULE TO
TENDER OFFER STATEMENT
UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934
SHARED MEDICAL SYSTEMS CORPORATION
(Name of Subject Company (Issuer))
AUTOBAHN ACQUISITION CORPORATION
A WHOLLY OWNED SUBSIDIARY OF
SIEMENS CORPORATION
AN INDIRECT WHOLLY OWNED SUBSIDIARY OF
SIEMENS AKTIENGESELLSCHAFT
(Name of Filing Person (Offeror))
COMMON STOCK,
PAR VALUE $0.01
PER SHARE
(Title of Class of Securities)
819486101
(CUSIP Number of Class of Securities)
KENNETH R. MEYERS
SIEMENS CORPORATION
153 EAST 53RD STREET
NEW YORK, NEW YORK 10022
(212) 258-4000
with a copy to:
BENJAMIN F. STAPLETON III, ESQ.
SULLIVAN & CROMWELL
125 BROAD STREET
NEW YORK, NEW YORK 10004-2498
(212) 558-4000
(Name, address, and telephone numbers of person authorized
to receive notices and communications on behalf of filing persons)
--------------------------------------------------------------------------------
CALCULATION OF FILING FEE
Transaction valuation Amount of filing fee
Not Applicable
--------------------------------------------------------------------------------
Check the appropriate boxes below to designate any transactions to which the
statement relates:
[X] third-party tender offer subject to Rule 14d-1.
[ ] issuer tender offer subject to Rule 13e-4.
[ ] going-private transaction subject to Rule 13e-3.
[ ] amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the results
of the tender offer: [ ]
<PAGE>
ITEMS 1 - 10.
N/A
ITEM 11. ADDITIONAL INFORMATION.
The Expiration Date of the Offer which was scheduled for 12:00
midnight, New York City time, on Wednesday, June 7, 2000 has been extended
to 12:00 midnight, New York City time, on Friday, June 30, 2000, unless the
Offer is further extended.
In addition on June 7, 2000, Siemens Medical Engineering Group issued a
press release announcing the extension of the Expiration Date, which is
attached as an exhibit hereto.
ITEM 12. MATERIAL TO BE FILED AS EXHIBITS.
Item 12 is hereby amended to add the following:
(a) Press release issued by Siemens Medical Engineering Group, dated June 7,
2000, announcing the extension of the Expiration Date.
<PAGE>
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: June 7, 2000 Autobahn Acquisition Corporation
/s/ Michael W. Schiefen
-----------------------------------
Name: Michael W. Schiefen
Title: President
/s/ E. Robert Lupone
-----------------------------------
Name: E. Robert Lupone
Title: Vice President
Siemens Corporation
/s/ Michael W. Schiefen
-----------------------------------
Name: Michael W. Schiefen
Title: Vice President-Corporate
Development
/s/ E. Robert Lupone
-----------------------------------
Name: E. Robert Lupone
Title: Vice President, General
Counsel and Secretary
Siemens Aktiengesellschaft
/s/ Goetz Steinhardt
-----------------------------------
Name: Goetz Steinhardt
Title: Corporate Vice President
Group Executive Medical Engineering
/s/ Robert Kirschbaum
-----------------------------------
Name: Robert Kirschbaum
Title: Corporate Legal Counsel
